Discover (magazine)

Seed Health Launches Gut-Brain Development Program with Axial Therapeutics To Translate Caltech Research into Probiotic Innovations for Neuropsychiatric Health

Retrieved on: 
Wednesday, July 13, 2022
Movement, Genius, Biophysical environment, Discover (magazine), Anxiety, Communication, Student, Program, Education, CSO, LOS, California Institute for Quantitative Biosciences, Probiotic, Hope, Therapy, Cognition, Luis, CEO, Neurodegeneration, Emotion, Hypothalamus, Brain, MacArthur Foundation, Depression, Autism, Alzheimer's disease, Biodiversity, Parkinson's disease, Medicine, Division, J&J, Mental health, Skin, Reproductive health, Central nervous system, Human, Disorder, Pediatrics, Research, Board, CNS, Health, Industry, Behavior, Drug development, Social, Seed, Dietary supplement, Birth control, Medical imaging, Pharmaceutical industry, Nature, Axial, Science, California Institute of Technology, Microbiology, Biology

LOS ANGELES and BOSTON, July 13, 2022 /PRNewswire/ -- Seed Health, a microbiome science company, and Axial Therapeutics, a clinical-stage biopharmaceutical company, today announced a joint development program targeting the microbiome-gut-brain axis for mental health, with the potential to impact well-being in areas like anxiety, depression and stress response. The program builds on the work of Axial co-founder and Board Member and Seed Health Board Member Dr. Sarkis Mazmanian, whose California Institute of Technology (Caltech) lab first discovered the critical contributions of intestinal microbes and microbial metabolites in neuropsychiatric conditions. With joint expertise across discovery, mechanistic validation, microbial fermentation, scale-up, clinical research and commercialization, the program is uniquely positioned to transform the current paradigm of treatment in mental health.

Key Points: 
  • Dr. Mazmanian's lab was the first to discover that molecular signals from gut bacteria can profoundly influence anxiety behavior.
  • The collaboration between Seed Health and Axial Therapeutics will translate this breakthrough research into novel probiotics and living medicines for a range of cognitive and neuropsychiatric outcomes."
  • Seed Health is a microbiome science company pioneering innovations in probiotics and living medicines to impact human and planetary health.
  • Axial Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of gut-restricted, small molecule therapeutics for central nervous system (CNS) disorders.

Seed Health Launches Gut-Brain Development Program with Axial Therapeutics To Translate Caltech Research into Probiotic Innovations for Neuropsychiatric Health

Retrieved on: 
Wednesday, July 13, 2022
Movement, Genius, Biophysical environment, Discover (magazine), Anxiety, Communication, Student, Program, Education, CSO, LOS, California Institute for Quantitative Biosciences, Probiotic, Hope, Therapy, Cognition, Luis, CEO, Neurodegeneration, Emotion, Hypothalamus, Brain, MacArthur Foundation, Depression, Autism, Alzheimer's disease, Biodiversity, Parkinson's disease, Medicine, Division, J&J, Mental health, Skin, Reproductive health, Central nervous system, Human, Disorder, Pediatrics, Research, Board, CNS, Health, Industry, Behavior, Drug development, Social, Seed, Dietary supplement, Birth control, Medical imaging, Pharmaceutical industry, Nature, Axial, Science, California Institute of Technology, Microbiology, Biology

LOS ANGELES and BOSTON, July 13, 2022 /PRNewswire/ -- Seed Health, a microbiome science company, and Axial Therapeutics, a clinical-stage biopharmaceutical company, today announced a joint development program targeting the microbiome-gut-brain axis for mental health, with the potential to impact well-being in areas like anxiety, depression and stress response. The program builds on the work of Axial co-founder and Board Member and Seed Health Board Member Dr. Sarkis Mazmanian, whose California Institute of Technology (Caltech) lab first discovered the critical contributions of intestinal microbes and microbial metabolites in neuropsychiatric conditions. With joint expertise across discovery, mechanistic validation, microbial fermentation, scale-up, clinical research and commercialization, the program is uniquely positioned to transform the current paradigm of treatment in mental health.

Key Points: 
  • Dr. Mazmanian's lab was the first to discover that molecular signals from gut bacteria can profoundly influence anxiety behavior.
  • The collaboration between Seed Health and Axial Therapeutics will translate this breakthrough research into novel probiotics and living medicines for a range of cognitive and neuropsychiatric outcomes."
  • Seed Health is a microbiome science company pioneering innovations in probiotics and living medicines to impact human and planetary health.
  • Axial Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of gut-restricted, small molecule therapeutics for central nervous system (CNS) disorders.

USRA Establishes the Judith L. Pipher Memorial Scholarship Award

Retrieved on: 
Monday, June 27, 2022
Infrared, Memory, Science, Life, CEO, Universities Space Research Association, Research, Catherine Helen Spence Memorial Scholarships, Chair, Unitary state, Student, National academy, Engineering, Government, University, Association, Cross-Cutting Programs Committee, Emeritus, Astronomy, USRA, COI, STEM, Technology, Susan, National, Leadership, Discover (magazine), Education, Medical device, Management, Telescope

COLUMBIA, Md., June 27, 2022 /PRNewswire/ --Universities Space Research Association (USRA) proudly announces the addition of a new awardthe Judith L. Pipher Memorial Scholarship Awardto honor the memory of Dr. Judith L. Pipher.

Key Points: 
  • COLUMBIA, Md., June 27, 2022 /PRNewswire/ --Universities Space Research Association (USRA) proudly announces the addition of a new awardthe Judith L. Pipher Memorial Scholarship Awardto honor the memory of Dr. Judith L. Pipher.
  • With the establishment of this new award, USRA will now routinely offer five Distinguished Undergraduate Award scholarships.
  • Dr. Pipher served Universities Space Research Association in various capacities, including Vice Chair of the USRA Board; USRA Region II Trustee; University of Rochester Representative to the USRA Council of Institutions (COI); Member, COI Issues and Program Committee; and Chair, USRA SOFIA Science Council.
  • We hope this Memorial Scholarship will honor Judy's memory, as well as her many contributions to science and STEM education."

anthym Welcomes Dr. Matthew Lieberman to Its Scientific Advisory Council

Retrieved on: 
Tuesday, May 24, 2022
Quotient, People, Social cognitive neuroscience, UCLA, Psychological Science, National Science Foundation, Mental health, National Institute, Magnetic resonance imaging, DARPA, The New York Times, Connection, Time, Workplace, Social, Infrared spectroscopy, Research, APA Distinguished Scientific Award for an Early Career Contribution to Psychology, Los Angeles Times Book Prize, Harvard University, National Institute of Mental Health, Social cognition, Scientific American, Organization, Discover (magazine), Reading, ABC, Magnetic resonance, What, Connect, LinkedIn, Twitter, Loneliness, CEO, Guggenheim Foundation, Management, Psychology, Science, Nightline, Resonance

PHOENIX, May 24, 2022 /PRNewswire/ -- anthym , a leading human-centered new hire onboarding & team connection platform for a remote-first workforce, today announced a key addition to its Social Science Advisory Council in Dr. Matthew Lieberman.

Key Points: 
  • PHOENIX, May 24, 2022 /PRNewswire/ -- anthym , a leading human-centered new hire onboarding & team connection platform for a remote-first workforce, today announced a key addition to its Social Science Advisory Council in Dr. Matthew Lieberman.
  • Dr. Lieberman will advise the company as it continues to innovate around its new connection & culture measurement methodology called Connection Quotient (CQ) .
  • "I am thrilled to welcome Dr. Matthew Lieberman to the anthym Social Science Advisory Council," said Brian Mohr, Co-founder & CEO of anthym.
  • Dr. Lieberman is equally excited to be involved with anthym given his view that "What anthym is doing is really essential.

Flux Marine Raises $15.5 Million in Oversubscribed Series A Round to Electrify Marine Outboards

Retrieved on: 
Wednesday, March 30, 2022
Zero, Climate change, Transport, TED (conference), The Washington Post, CO2, Flux, RI, HP, Noise, CEO, Discover (magazine), River, Lake, Gasoline, LLC, Technology, Atmosphere, Science, Acceleration, R, Maintenance, Engineering, Airline, Electric motor, Propane, BRISTOL

BRISTOL, R.I. , March 30, 2022 /PRNewswire/ -- Flux Marine, a trailblazing developer of all-electric outboard motors and battery systems for watercraft, today announced it raised $15.5 million in an oversubscribed Series A funding round led by Ocean Zero LLC. Flux Marine will leverage the new funding to expand manufacturing, recruit additional talent, and continue to develop its advanced technologies. 

Key Points: 
  • Flux Marine will leverage the new funding to expand manufacturing, recruit additional talent, and continue to develop its advanced technologies.
  • By completely redesigning the outboard motor to deliver zero-emissions power, Flux Marine electric outboards exceed the performance of fossil-fuel engines.
  • Flux Marine also enjoyed participation in this round from Boost VC and Winklevoss Capital , and saw majority participation from previous seed and angel investors.
  • Headquartered in Bristol, RI, Flux Marine is advancing electric marine propulsion technology to deliver the world's best boating experiences.

A New Platform to Discover Science Experiences Anytime, Anywhere.

Retrieved on: 
Friday, January 28, 2022
Association of Science and Technology Centers, American Association, Citizen science, National Science Foundation, Learning, Organization, University, American Association for Laboratory Animal Science, Museum, Policy, Center, MIT Museum, Research Institute for Advanced Computer Science, Engineering, Discover (magazine), Technology, Evaluation, COSI, Research, Cavalier, Association, Oregon State University, SciStarter, National Center for Research on Evaluation, Standards, and Student Testing, Management, Pharmaceutical industry, STEM, Science

"Millions of people are seeking opportunities to act upon issues they find interesting or concerning," says Darlene Cavalier, founder of SciStarter , a leading platform for citizen science, and a Science Near Me co-founder.

Key Points: 
  • "Millions of people are seeking opportunities to act upon issues they find interesting or concerning," says Darlene Cavalier, founder of SciStarter , a leading platform for citizen science, and a Science Near Me co-founder.
  • With a broad roster of national and regional partners, and funding from the National Science Foundation, Science Near Me is uniting traditionally separate offerings from museums, science festivals, citizen science, science policy forums, after-school programs, maker programs, astronomy clubs and more.
  • Science Near Me aggregates thousands of STEM events, projects, and programs hosted by a wide range of organizations across the U.S.
  • Science Near Me, a subsidiary of SciStarter.org , aggregates a diverse array of opportunities for the public to engage in science.